The "Plaque Modification Devices - Market Insights, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The plaque modification devices market was valued ...

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final two rounds ...

Medtronic (NYSE:MDT) announced results from two studies evaluating the utility of atherectomy for peripheral endovascular interventions.

Abbott has delivered new, longer-term data from a clinical study of its dissolving stent for severe peripheral artery disease ...

[Image from the Abbott website] Abbott (NYSE:ABT) today announced data demonstrating the long-term effectiveness of its ...

Abbott has unveiled positive long-term data for its Esprit below-the-knee (BTK) stent in treating the most severe form of peripheral artery disease (PAD). The data, which was presented as a ...

Peripheral artery disease is increasingly prevalent with disease presentations ranging from the asymptomatic patient to the patient with an ischemic or threatened lower extremity. The role of the ...

Its effect is likely to be the result of reduced distal embolization and, thus, improved myocardial reperfusion, as well as more precise assessment of stent parameters. It also favors direct ...

Below-the-knee (BTK) arterial disease represents a significant challenge in peripheral artery disease (PAD ... variety of drug-eluting bioresorbable scaffolds (DRS). Bioresorbable stents (BRS) were ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...